Johnson & Johnson vs Medline Inc.
JNJ vs MDLN — side-by-side comparison from reported financials. JNJ leads 7, MDLN leads 2 of 9 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Medline Inc.
MDLN · Healthcare
$36.29+1.54%Solid
| Metric | JNJ | MDLN |
|---|---|---|
| Price | $261.79 | $36.29 |
| Market cap | $631B | $31.8B |
| Revenue (TTM) | $97.9B | $29.9B |
| Revenue growth | +5.6% | +9.8% |
| Net margin | 21.5% | 1.7% |
| Free cash flow | $22.2B | $1.58B |
| Net cash (debt) | ($27.8B) | ($10.6B) |
| 1-year price return | +37.0% | — |
| P/E | 29.9 | 68.8 |
| P/E vs own history (cheap-side %) | 16% | 15% |
| Dividend yield | 2.00% | — |
| Return on equity | 26% | 5% |
| Altman Z-score | — | 1.65 |
| CV checks passed | 10 of 11 | 5 of 11 |
| Employees | 140,800 | 45,000 |
Full résumé-style profiles: JNJ CV · MDLN CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.